Podcast Episodes
Back to SearchNEJM February 5,2026 Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.
This meta-analysis investigated whether prescribing beta-blockersprovides any clinical benefit to heart attack survivors who maintain a normal ejecti…
8 months, 1 week ago
NEJM February 5,2026:A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
This study examines the effectiveness of enlicitide, a novel oral PCSK9 inhibitor, in treating patients with a genetic predisposition for dangerously…
8 months, 1 week ago
American Journal of HTN January 2026 Trends in Initial Combination Antihypertensive Therapy in a US Health System
Source guide This study examines a concerning shift in medical practice by tracking how often doctors prescribe multiple medications simultaneously t…
8 months, 1 week ago
JAMA Network Open ID Single-Dose Liposomal Amphotericin Plus Fluconazole and Flucytosine for Cryptococcal Meningitis at a US Public Hospital
This research study evaluates a streamlined treatment method for cryptococcal meningitis, a dangerous fungal brain infection that frequently affects …
8 months, 1 week ago
NEJM January 28, 2026: A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
This research study evaluates the effectiveness of two experimental drugs, tobevibart and elebsiran, in treating chronic hepatitis D, a serious viral…
8 months, 2 weeks ago
NEJM January 28,2026 Nivolumab for Resected Stage III or IV Melanoma at 9 Years
The provided text details the long-term results of the CheckMate 238 clinical trial, which evaluated the effectiveness of two immunotherapy drugs in …
8 months, 2 weeks ago
NEJM January 28,2026 Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
This clinical study investigates whether patients who have undergone a successful catheter ablation for atrial fibrillation still require powerful an…
8 months, 2 weeks ago
NEJM January 22,2026 Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
This clinical study investigates a promising new treatment combination for patients facing advanced triple-negative breast cancer, a particularly agg…
8 months, 3 weeks ago
NEJM January 22,2026:Nivolumab for Resected Stage III or IV Melanoma at 9 Years
This long-term clinical study evaluates the effectiveness of two different immunotherapy drugs in preventing the return of advanced melanoma followin…
8 months, 3 weeks ago
NEJM January 22,2026:Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation.
This clinical trial investigated whether patients who underwent a successful catheter ablation for atrial fibrillation still require powerful blood t…
8 months, 3 weeks ago